sequencing,143.txt
five-yearOsRate,86.txt
fxyd3Amplification,189.txt
it,199.txt
remarkableEnzyme-activatedNirFluorescentProbeNir-sn-ggt,29.txt
we,44.txt
features,32.txt
treatment,6.txt
we,132.txt
pathologicalSpecimen,10.txt
circulatingExosomes,206.txt
involvement,85.txt
We,134.txt
epigeneticMarkers,226.txt
resonanceImaging,121.txt
They,57.txt
Ki67,74.txt
recentDanishCohortStudy,208.txt
p27,106.txt
elevatedMitochondrialFission,77.txt
22Patients,196.txt
transcriptionFactorForkheadBoxC1,105.txt
mriTechniques,207.txt
resistance,70.txt
role,44.txt
Survival,80.txt
carcinoma,236.txt
differentialDiagnosis,220.txt
mortalityRate,50.txt
We,4.txt
nanoplatform,159.txt
aim,87.txt
importance,95.txt
Women,174.txt
extensiveExploration,80.txt
we,101.txt
serumCrust,78.txt
breastCancer,100.txt
treatment,220.txt
roles,131.txt
signature,190.txt
strategies,98.txt
disturbance,77.txt
massMedia,64.txt
pathways,50.txt
chemotherapyDrugs,46.txt
bioactivity,153.txt
participants,129.txt
impact,167.txt
complications,164.txt
23Patients,72.txt
scope,35.txt
hospitalizations,179.txt
carboxyl-modifiedPegylatedPoly,159.txt
goodTolerabilitytheApatinib,196.txt
SOX9,131.txt
sparseCoding,59.txt
complexTreatmentAlgorithms,231.txt
RT,93.txt
adhesionProtein-1,246.txt
dynamicSh2Domain-scaffoldingProteinComplexes,211.txt
epigeneticChanges,226.txt
rnaOligonucleotides,55.txt
detectionofBreastCancer,144.txt
treatment,206.txt
accuracyScores,114.txt
multipleGeneticAberrances,197.txt
increase,219.txt
protocol,75.txt
it,175.txt
medicalKnowledge,94.txt
proportion,109.txt
included,200.txt
response,153.txt
mainMeasures,118.txt
tomography,116.txt
We,66.txt
otherFactors,244.txt
associations,88.txt
patients,103.txt
lack,201.txt
incidence,66.txt
five-yearMetastasis-free,72.txt
coxModel,102.txt
analyses,152.txt
research,32.txt
breastCancer,113.txt
sexualityMoreEvidence,57.txt
pathway,189.txt
improvement,2.txt
adults,232.txt
patients,4.txt
breastReconstruction,69.txt
Management,180.txt
breastCancer,120.txt
MRI,11.txt
metabolicTargetVolume,104.txt
treatment,118.txt
therapeuticSequencing,143.txt
interactionEffects,2.txt
craniotomy,10.txt
study,162.txt
document,92.txt
effects,219.txt
dissection,124.txt
case,107.txt
lungCancer,202.txt
glut1Expression,45.txt
complaint,32.txt
period,72.txt
approach,211.txt
pain,46.txt
We,68.txt
PF,51.txt
risk,117.txt
meta-analyses,219.txt
breastCancer,191.txt
0.84,101.txt
We,204.txt
we,73.txt
It,175.txt
tissueBiopsy,83.txt
screeningBehavior,138.txt
DDT,174.txt
usExaminations,194.txt
Patients,110.txt
dynamicContrast,184.txt
aim,16.txt
breastExamination,138.txt
advancedStage,39.txt
latencyTime,191.txt
adults,78.txt
surgicalExcision,37.txt
hormonalContraceptionUse,208.txt
correctDiagnosis,12.txt
patients,202.txt
strongLinkage,53.txt
t2Category,86.txt
gastricCancer,164.txt
commonCancer,193.txt
bindingSites,41.txt
positiveFeedbackLoop,77.txt
imbalance,84.txt
fewLmics,53.txt
mainTwoEntities,149.txt
incidenceTrendPlots,115.txt
search,200.txt
transport,45.txt
patients,130.txt
mammographicImages,144.txt
Patients,147.txt
variation,126.txt
antibodies,154.txt
solubleMediators,84.txt
fpReduction,49.txt
tumorWeight,162.txt
surgicalOutcome,147.txt
nano-genosensor,235.txt
apoptosis,244.txt
variants,110.txt
cent,217.txt
diagnosis,72.txt
polycysticOvarySyndrome,117.txt
brcanessPhenotype,135.txt
2-groupRandomizedControlTrial,22.txt
association,212.txt
andfemales,39.txt
multigenePanels-with,167.txt
anticipatedOutcome,22.txt
program,64.txt
proteinExpression,61.txt
recentStudies,233.txt
+239Percecnt,115.txt
Angiogenesis,71.txt
results,202.txt
costData,69.txt
understanding,109.txt
patients,158.txt
tissues,185.txt
elevatedLesion,6.txt
little,99.txt
ourData,77.txt
surgicalImplantationReconstruction,118.txt
breastCancer,182.txt
treatments,76.txt
specificSubtype,127.txt
We,200.txt
commonOnes,215.txt
proportion,187.txt
associations,183.txt
aptamerMf3,55.txt
patients,73.txt
targetedTherapies,168.txt
patients,95.txt
circRNAs,137.txt
survival,86.txt
study,85.txt
resistantCells,198.txt
significantDifference,196.txt
women,226.txt
none,46.txt
Use,245.txt
networkOutput,83.txt
neuropathicPain,46.txt
advance,198.txt
microRNAs,20.txt
multidimensionalScaling,111.txt
radiotherapy,93.txt
majorObstacle,125.txt
individuals,66.txt
nuclearFactors,84.txt
sox9NucleusEntry,189.txt
immediateReconstruction,69.txt
SPIO,159.txt
secondaryLymphomatousInvolvement,43.txt
,231.txt
vulnerability,174.txt
medianLatencyPeriod,72.txt
severalPatients,228.txt
brainMetastases,4.txt
youngMen,103.txt
65-year-oldFemale,10.txt
top10InformationalNeedContents,23.txt
ageGroups,188.txt
ourStudy,41.txt
relationship,174.txt
expectedInverseCorrelation,174.txt
exposure,243.txt
article,93.txt
RON,128.txt
suchStandardization,167.txt
AMD3100,105.txt
Rainbow,112.txt
rapidAdvancements,72.txt
model,7.txt
anti-her2Therapy,139.txt
guidePatients,51.txt
Overexpression,200.txt
complexSemisolidMasses,43.txt
cancer,20.txt
involvement,30.txt
proteinKinaseCInhibitors,46.txt
pD1542yMissenseMutation,197.txt
chemotherapyHormonalTreatment,96.txt
anticoagulantChoice,160.txt
breastCancer,157.txt
It,65.txt
antigenIdentification,154.txt
breastCancer,43.txt
STAT1,70.txt
theory-basedIntervention,22.txt
mildHyperthermia,198.txt
concentrations,174.txt
patient,67.txt
handicap,114.txt
Lack,74.txt
newFpReductionTechnique,49.txt
women,187.txt
haveCenterstage,9.txt
commonFinding,57.txt
patients,147.txt
theirCardiotoxicities,139.txt
Protocadherin-10,185.txt
traditionalPredictors,190.txt
hsa_circRNA_102101,137.txt
percecnt,129.txt
reports,72.txt
tenfoldCross-validationMatthew,192.txt
it,234.txt
40,103.txt
complication,152.txt
high-gradeSarcomas,72.txt
third-degree,202.txt
aggressiveManagement,166.txt
all,182.txt
method,83.txt
patients,167.txt
56Patients,184.txt
differentPrognosis,120.txt
We,110.txt
lungAdenocarcinomas,12.txt
cavernousMalformationInduction,73.txt
age,164.txt
results,189.txt
expression,189.txt
solubleSt-2Level,163.txt
activity,18.txt
plasmaLevels,16.txt
cancer,244.txt
challenges,53.txt
fastingBlood,163.txt
Number,104.txt
risk-stratifiedScreeningStrategy,79.txt
blood,163.txt
lowClassificationAccuracies,236.txt
rareTumor,10.txt
fpReductionTechnique,49.txt
pathologicalResults,32.txt
imaging,167.txt
18FemaleNudeMice,162.txt
t2bSutegory,86.txt
hugeVolumes,40.txt
furtherImaging,215.txt
83Percecnt,12.txt
we,239.txt
it,221.txt
substantialImprovements,168.txt
resonanceImaging,31.txt
mostNondestructiveTests,7.txt
decision,31.txt
theirPyrrolizin-5-oneAnalogs,181.txt
algorithm,113.txt
breastCancerDiagnosis,138.txt
Prolactinomas,57.txt
factorAnalysis,111.txt
segmentationAlgorithm,144.txt
breast,98.txt
We,239.txt
risk,72.txt
syndrome,65.txt
Probes,9.txt
data,156.txt
proposedAlgorithm,113.txt
outcome,22.txt
allBreastCancerPatients,22.txt
Aspirin,219.txt
Fisher,89.txt
problem,36.txt
TP53,110.txt
breastCancer,225.txt
morc4Silencing,81.txt
ductalCarcinoma,37.txt
screeningTools,210.txt
We,174.txt
twoChlorambucilPlatinum,205.txt
individuals,147.txt
oncologyGroup,72.txt
factors,109.txt
clb-pt-clbProdrug,205.txt
patient,188.txt
compounds,181.txt
induction,180.txt
cross-validation,20.txt
49Patients,47.txt
effect,41.txt
density,31.txt
article,161.txt
osRate,86.txt
differentialExpression,137.txt
enhancerRegions,58.txt
sevenWomen,27.txt
mastitis,31.txt
article,105.txt
160Patients,47.txt
micrometastasis,26.txt
10Percecnt,12.txt
PCDH10,185.txt
localControl,217.txt
sexes,161.txt
magneticResonanceImaging,31.txt
challenge,41.txt
first,51.txt
sixCirculatingMirnas,120.txt
It,90.txt
knockdown,105.txt
independentReviewers,200.txt
Cases,1.txt
cowdenSyndrome,85.txt
drugDeliveryStrategies,168.txt
metformin,153.txt
commonAdultCancers,158.txt
propensityScoreMatchingAnalysis,103.txt
outcomes,102.txt
stageIv,119.txt
five-yearLocalRecurrenceRates,217.txt
unbiasedRnaSequenceAnalysis,70.txt
greatPromise,127.txt
consolidativeRadiotherapy,93.txt
palliativeChemotherapy,121.txt
cancer,130.txt
20-year-oldWoman,73.txt
paper,40.txt
prognosticValue,238.txt
mostBreastDiseases,232.txt
We,103.txt
we,121.txt
imaging,60.txt
examination,232.txt
therapy,191.txt
insight,37.txt
inhibited,82.txt
correlation,116.txt
imageQuality,224.txt
osteopontin-750Accumulation,134.txt
cancerSurvivors,179.txt
secondLargestHmo,64.txt
resultsExpression,71.txt
cm,86.txt
sosReconstruction,36.txt
cancer,233.txt
currentBio-sensingTechniques,239.txt
prospectiveNestedCase-controlStudy,174.txt
careProvider,91.txt
newSignalPattern,206.txt
adherence,96.txt
drugTherapy,76.txt
535941Survivors,118.txt
magneticResonanceImaging,121.txt
obesity,146.txt
results,95.txt
beta-Sitosterol-d-glucoside,244.txt
eConcentration,26.txt
we,112.txt
additionalInformation,1.txt
screening,79.txt
it,135.txt
patients,80.txt
we,161.txt
inverseProblem,36.txt
breastCancer,87.txt
Promoting,186.txt
percecnt,141.txt
We,211.txt
identified,214.txt
dnaMethylation,58.txt
risks,145.txt
methylation,127.txt
involved,135.txt
mStage,32.txt
FXYD3,189.txt
invasiveDuctalCarcinoma,236.txt
study,47.txt
subgroupVariables,103.txt
bleedingRates,160.txt
sustainedStableDisease,197.txt
LMICs,53.txt
longerPfs,4.txt
metastaticDisease,1.txt
ourProposedMethod,36.txt
age-basedScreeningPrograms,79.txt
murineMonoclonalAntibodies,154.txt
patients,169.txt
mainContribution,7.txt
manyWomen,50.txt
promoterdnaMethylation,41.txt
inhibitors,216.txt
crcPatients,206.txt
we,190.txt
metastasis,121.txt
online,23.txt
receptorActivator,56.txt
highestRisk,188.txt
review,80.txt
cardiacTroponins,142.txt
existence,190.txt
history,163.txt
patient'sHistory,166.txt
we,149.txt
development,223.txt
localTherapy,143.txt
pax6Overexpression,41.txt
experience,231.txt
oneMutation,241.txt
firstDose,25.txt
Patients,152.txt
PAX8,12.txt
carcinoma,67.txt
mtorInhibitorEverolimus,197.txt
breastCancers,161.txt
herPresentation,139.txt
treatment,57.txt
inclusion,226.txt
presence,7.txt
adverseEffects,219.txt
results,208.txt
its,174.txt
clinicalCharacteristics,111.txt
long-termUse,22.txt
QALY,69.txt
towaveletFilter,144.txt
hypoxia,156.txt
breastConservation,109.txt
occultBreastTumors,21.txt
estrogenReceptorBeta,140.txt
femalePatients,202.txt
tumor,83.txt
development,76.txt
breastConservation,143.txt
patients,204.txt
prognosis,167.txt
vitaminD,95.txt
tumors,57.txt
role,71.txt
Patients,118.txt
lesions,166.txt
analysis,204.txt
preoperativeUnderstanding,109.txt
lateComplications,164.txt
technique,116.txt
RNAs,190.txt
breastCancer,108.txt
outcomes,182.txt
tripentoneDerivatives,181.txt
severalHer2-targetedTherapies,201.txt
we,231.txt
study,210.txt
Isolation,178.txt
standard,241.txt
NSAIDs,66.txt
complexConsulting,231.txt
effectiveness,237.txt
MicroRNAs,235.txt
percecnt,147.txt
mastectomy,147.txt
histopathologicalAnalysis,31.txt
woman,187.txt
preventiveStrategies,98.txt
postmenopausalPatient,220.txt
informationNeeds,23.txt
We,240.txt
ourResults,190.txt
number,182.txt
model,188.txt
ourResults,105.txt
infiltrationSimilar,6.txt
disease,222.txt
main,1.txt
ourFindings,118.txt
imaging,215.txt
it,1.txt
post-radiationVascularLesions,149.txt
studies,104.txt
evaluation,15.txt
prospectiveStudies,102.txt
cellCultureSupernatants,206.txt
twoIndependentReviewers,200.txt
inImaging,162.txt
we,110.txt
detection,144.txt
theirSurvival,118.txt
coding,59.txt
it,195.txt
Studies,179.txt
womenCarriers,98.txt
accurateMethod,83.txt
patients,237.txt
prediction,113.txt
furtherStudies,104.txt
featureSubset,170.txt
diagnosticPfBiomarkers,51.txt
women,33.txt
identified,92.txt
development,29.txt
circulatingBiomarkers,239.txt
relapse,80.txt
lymphedemaseventyPatients,19.txt
advancedBreastCancer,100.txt
robustSynthesisMethods,9.txt
evolutionaryConservedCircularRnas,137.txt
filipinoWomen,138.txt
microRNAs,71.txt
networks,83.txt
metastasis,215.txt
biocompatiblePfh-ptx@plga,159.txt
otherAgeGroups,188.txt
SVM-BRC,20.txt
diagnosed,118.txt
brd4PharmacologicalInhibition,135.txt
chlorambucilPlatinum,205.txt
subtypes,102.txt
Analysis,169.txt
we,194.txt
we,183.txt
evaluation,220.txt
vdrPolymorphisms,95.txt
discovery,132.txt
deep-CNN,101.txt
Kazakhstan,145.txt
breastCancer,144.txt
assessment,240.txt
prevention,95.txt
histology,152.txt
study,32.txt
breastCancer,159.txt
SNPs,13.txt
pax6promoterMethylation,41.txt
challenge,241.txt
We,152.txt
commonCause,17.txt
morphology,77.txt
it,207.txt
patients,39.txt
we,192.txt
twoTumorGroups,153.txt
mitochondrialTransmembranePotential-drivenRegulatedCellDeaths,173.txt
Factors,145.txt
action,95.txt
highCorrelation,37.txt
description,183.txt
ca125-richExosomes,206.txt
status,165.txt
cohortStudy,208.txt
riskFactors,164.txt
99Percecnt,129.txt
Resection,73.txt
rate,42.txt
speed,175.txt
follow-up,188.txt
breastCancer,58.txt
studies,133.txt
one-thirdCases,201.txt
mrnaLevels,162.txt
factors,84.txt
locoregionalRadiotherapy,222.txt
imageSegmentation,175.txt
biologicalHeterogeneity,74.txt
jak-statPathway,70.txt
population,195.txt
dual-luciferaseReporterAssays,81.txt
We,222.txt
immunohistochemicalProliferationMarkerKi67,74.txt
similarities,23.txt
we,156.txt
highGlut1Expression,45.txt
107ObservationalStudies,200.txt
We,84.txt
hospitalizedBleedingRisk,160.txt
oneCancer,53.txt
study,7.txt
She,97.txt
sutegories,86.txt
aim,115.txt
biopsy,121.txt
tumorInformation,23.txt
Radiotherapy,118.txt
pattern,93.txt
Recurrences,188.txt
breast,207.txt
effects,217.txt
strongContrast,210.txt
experts,92.txt
youngPatients,202.txt
aim,238.txt
postmenopausalWomen,216.txt
Hsa_circ_000178,137.txt
aberrantExpression,191.txt
trastuzumab/pertuzumab/taxane,4.txt
multivariate,238.txt
patients,196.txt
recurrence-free-survival,147.txt
Development,92.txt
chemotherapyGroups,102.txt
dataAnalytics,40.txt
22Patients,150.txt
betterOs,103.txt
hyperthermia,198.txt
medianLatencyTime,191.txt
function,172.txt
analysis,97.txt
microrna-22ExpressionLevels,18.txt
intraoperativeScrapeCytology,52.txt
0-5Years,24.txt
scope,62.txt
increases,7.txt
score,194.txt
use,142.txt
breastCancer,45.txt
personalDecision-making,64.txt
vdrExpression,95.txt
Follow-up,188.txt
countries,53.txt
polymorphismsImportant,95.txt
proteinKinaseCInhibition,46.txt
know-howWe,112.txt
lesion,6.txt
dichlorofluoresceinLevel,173.txt
value,14.txt
similarSeriousAdverseEvents,196.txt
result,144.txt
study,241.txt
mothers,183.txt
objective,108.txt
patient,139.txt
increasedRonExpression,128.txt
sampleSizes,200.txt
she,107.txt
years,24.txt
additionalAnalyses,229.txt
combinedAnalysis,16.txt
Investigation,174.txt
We,158.txt
aim,203.txt
inhibition,70.txt
clinicalDepression,111.txt
patient'sMedicalHistory,6.txt
cause,85.txt
late-stageCancerDiagnosis,145.txt
perceivedWorkAbility,2.txt
osteopontin-basedProbe,134.txt
members,85.txt
delay,193.txt
physicalActivity,242.txt
components,136.txt
epigeneticAberrations,225.txt
meanTime,174.txt
twenty-twoPatients,196.txt
syndrome,117.txt
participants,2.txt
recurrence,147.txt
Validation,21.txt
emergingTechnology,101.txt
risk,160.txt
186Pathology-provenS,194.txt
itsRelativeClinicalSignificance,172.txt
disruption,65.txt
medianFollow-upPeriod,86.txt
it,148.txt
evidence,193.txt
We,93.txt
We,19.txt
these,186.txt
DESI-MSI,236.txt
dose,25.txt
standard,52.txt
characterization,175.txt
stableDrug-carrierBinding,9.txt
significance,238.txt
kmt2aFusionGeneTranscripts,191.txt
its,125.txt
We,101.txt
Patients,228.txt
rateIncrease,161.txt
We,154.txt
rates,160.txt
it,69.txt
APBI,217.txt
patients,206.txt
study,102.txt
advancedAnalysis,13.txt
significantDifference,183.txt
survivalData,4.txt
existence,8.txt
commonPrimaryLesion,72.txt
undifferentiatedNeoplasticCells,6.txt
positiveChanges,129.txt
distinction,149.txt
treatment,196.txt
oneSpecificSubtype,127.txt
patient,166.txt
case,220.txt
mriProtocols,207.txt
muchFocus,195.txt
twoPathways,50.txt
we,213.txt
particleSwarmOptimizationAlgorithm,170.txt
ourPatient,67.txt
rnaKnockdown,81.txt
superiorVenaCavaSyndrome,65.txt
importance,129.txt
findings,240.txt
standardizedImagingProtocol,207.txt
cases,38.txt
alternativeOption,33.txt
26,200.txt
simulation,36.txt
familySupport,214.txt
statisticalClassifiers,236.txt
mutations,158.txt
aim,61.txt
cases,146.txt
total,190.txt
HT,26.txt
higherDetectionRates,155.txt
molecularTesting,51.txt
AION,210.txt
contrast-enhancedSpectralMammography,34.txt
positronEmissionTomography,104.txt
largerStudies,71.txt
circularRnas,137.txt
significantHigherRisk,117.txt
surfaceArea,239.txt
We,220.txt
transcoelomic,43.txt
deepLearning,114.txt
stage,109.txt
nondestructiveTesting,7.txt
differentProtocols,8.txt
continuousRisk,93.txt
percecnt,202.txt
results,116.txt
similarPfs,4.txt
cell,178.txt
clinicalCharacteristics,1.txt
double-maintenanceTherapy,4.txt
membraneTypeMannoseReceptor,132.txt
Individuals,158.txt
women,35.txt
propagation-basedPhase-contrast,224.txt
considerableNumber,26.txt
results,40.txt
nsclcSamples,172.txt
techniques,113.txt
capacitance,176.txt
freshLeafEthanolicExtract-treatedMda-mb-231CellDeath,173.txt
It,94.txt
it,166.txt
Hyperprolactinemia,57.txt
leafMda-mb-231CellDeath,173.txt
st-2Level,163.txt
tanUsage,40.txt
we,24.txt
breastCancer,49.txt
convolutionalNeuralNetworks,83.txt
dysregulation,226.txt
subsequentRadiomics,194.txt
moreIntensiveFollow-up,188.txt
manyBreastCancerPatients,114.txt
anti-her2Therapies,139.txt
hugeImprovement,49.txt
age,1.txt
studies,142.txt
tumorGroups,153.txt
CNVs,192.txt
CLP,89.txt
incidenceRates,115.txt
sensor,176.txt
pharmacologicalInduction,135.txt
Comparisons,187.txt
pathogenicVariants,110.txt
learning,114.txt
world,112.txt
nirProbeNir-sn-ggt,29.txt
metastasis,147.txt
tools,157.txt
molecularAnalyses,152.txt
bilateralInvolvement,43.txt
evaluation,114.txt
exosomesDerivedCk19,206.txt
medianOverallSurvival,191.txt
relativeHospitalizedBleedingRisk,160.txt
those,241.txt
time,207.txt
identification,95.txt
700,236.txt
Referrals,145.txt
Tamoxifen,199.txt
lowerNewBloodVesselsFormation,162.txt
100Patients,146.txt
variousMethods,175.txt
SP,16.txt
contraceptionUse,208.txt
tumorSuppressorFunction,3.txt
breastCancerRisk,66.txt
breastCancer,41.txt
extremeLearningMachineClassification,175.txt
output,49.txt
feasibleCtcIsolationTechniques,178.txt
tumour,107.txt
it,30.txt
symptomaticWomen,33.txt
vap-1StainingResults,246.txt
betterUnderstanding,138.txt
manyPatients,195.txt
diagnosis,184.txt
technique,136.txt
cross-sectionalStudy,109.txt
diagnosis,193.txt
-1,48.txt
majority,151.txt
herDisease,139.txt
interview,47.txt
pattern,152.txt
review,217.txt
label-freeDetection,235.txt
cutoffValue,86.txt
clinicians,188.txt
15Percecnt,110.txt
paraneoplasticNeurologicSyndromes,67.txt
patients,46.txt
greatProgress,55.txt
diagnoses,232.txt
P,169.txt
directTargetGene,131.txt
brcc3ExpressionLevels,130.txt
frequentCancer,228.txt
breastBiopsies,34.txt
kmt2aFusionGenes,191.txt
mostStudies,219.txt
pdgfs/pdgfrsAxis,99.txt
we,77.txt
treatmentOutcomePrediction,120.txt
hyperglycemia,229.txt
microscopicTesting,83.txt
improvedUnderstanding,167.txt
hypothesis,79.txt
overexpression,105.txt
rareCases,12.txt
availableContrastAgents,210.txt
patients,185.txt
we,13.txt
colonyFormation,131.txt
reality,228.txt
patients,200.txt
metastasis,152.txt
They,208.txt
we,46.txt
therapies,168.txt
molecularChanges,225.txt
mostPretermBirth,180.txt
cancer,26.txt
we,154.txt
obstetrician,193.txt
sentinelNodeBiopsy,143.txt
women,129.txt
study,146.txt
ck5/6,51.txt
picture,224.txt
medianAge,1.txt
yearRfsrate,147.txt
objectiveResponseRate,196.txt
smallMoleculeInhibitors,136.txt
roboticSystem,122.txt
breastCancer,177.txt
drugBinding,9.txt
volume,19.txt
significance,7.txt
efforts,72.txt
54BreastCancerPatients,152.txt
surgery,122.txt
regressionAnalysis,164.txt
muchInterest,76.txt
compounds19a,209.txt
recognizingMethylationStatus,58.txt
mammographicBreastCancerScreening,33.txt
accuracy,113.txt
options,136.txt
effect,153.txt
opticalAbsorptions,116.txt
increasedRisk,179.txt
goal,157.txt
dcisDiagnosis,37.txt
breastCancerStudies,44.txt
studyObjective,200.txt
appropriateInterpretation,21.txt
activity,205.txt
randomisedTrials,25.txt
furtherResearch,32.txt
treatments,230.txt
ourAim,182.txt
subacuteEffects,217.txt
physicalActivity,165.txt
pik3caMutations,171.txt
It,49.txt
suutaneousBreastTumor,134.txt
simulatedBreastCancer,7.txt
multivariateCoxProportionalHazardRegressionAnalysis,117.txt
leafExtract,173.txt
we,143.txt
we,215.txt
role,37.txt
secondValuedApproach,50.txt
breastCancer,1.txt
patient,177.txt
risk,188.txt
diagnosis,175.txt
pseuderanthemumPalatiferumRadlkExtracts,173.txt
fisherAnalysis,184.txt
conventionalMagneticResonanceImaging,60.txt
testing,51.txt
counseling,96.txt
familyMembers,98.txt
parallelDetection,239.txt
interval,108.txt
reporterAssays,81.txt
model,21.txt
CK19,206.txt
separateClassificationModels,236.txt
chemotherapy,102.txt
review,219.txt
caloricRestriction,227.txt
cancerTherapy,153.txt
women,114.txt
P,196.txt
f-fdgPet/ct,104.txt
analysis,31.txt
overallMedianSurvival,100.txt
accuracy,7.txt
analysis,24.txt
ERN,94.txt
provision,23.txt
activeDerivatives,181.txt
oxidativeStressProbe,173.txt
it,72.txt
coxHazardRegressionModels,133.txt
advancedBreastCancerBearingMutations,197.txt
fiveYearRfsrate,147.txt
colorectalCancer,202.txt
morcFamilyCw-typeZincFinger4Overexpression,81.txt
genes,213.txt
breastCarcinomas,199.txt
geneExpressionLevel,61.txt
tendinopathy,216.txt
Lesions,166.txt
markedReduction,207.txt
mPatients,177.txt
research,92.txt
Targeting,70.txt
radiotherapy,222.txt
immunohistochemicalAnalysis,97.txt
proteins,239.txt
We,170.txt
8155Patients,117.txt
they,202.txt
ultrasound-guidedDiffuseOpticalTomography,116.txt
uptake,200.txt
mutations,141.txt
study,96.txt
people,186.txt
treatment,82.txt
CGI,58.txt
tamoxifen,199.txt
Metastasis,152.txt
postAssessment,147.txt
Efforts,207.txt
stereotacticWire-guidedBiopsy,121.txt
ourFindings,13.txt
ruralSetting,33.txt
twoScales,111.txt
application,170.txt
lesions,104.txt
potential,206.txt
neoadjuvantTreatment,102.txt
effects,187.txt
sensitiveNano-genosensor,235.txt
P,13.txt
Epidemiology,186.txt
cancer,11.txt
12404Patients,32.txt
switch,143.txt
gonadotropin,169.txt
controlGroup,22.txt
cleftLip/palate,89.txt
edition,167.txt
criticalScientificBase,225.txt
number,171.txt
clinicians,135.txt
it,137.txt
CK,51.txt
mixedMethodsDesign,177.txt
change,2.txt
mostPatients,1.txt
We,196.txt
five,132.txt
strategy,227.txt
divergences,115.txt
Co-existence,10.txt
Speed-of-sound,36.txt
practitionersKnowledgeable,151.txt
strategies,201.txt
trials,25.txt
keyHypomethylationSites,58.txt
12-15Percecnt,141.txt
percecnt,39.txt
node,60.txt
,141.txt
11HereditaryBreastCancerGenes,110.txt
We,145.txt
Mfn1,77.txt
27-36MillionPatients,94.txt
secondaryLymphedema,19.txt
leucocytes,154.txt
Cases,72.txt
erEvaluation,245.txt
subtype-specificSignature,218.txt
invasiveLobularHistology,152.txt
primaryCareProvider,91.txt
adjuvantRadiotherapy,126.txt
survival,4.txt
systematicSearch,200.txt
increase,22.txt
treatment,231.txt
development,159.txt
malformationInduction,73.txt
conventionalX-rayMammography,210.txt
evidence,186.txt
lesion,73.txt
breastCancer,21.txt
Patients,169.txt
dictionaryLearning,59.txt
study,119.txt
we,17.txt
promoterMethylationStatus,185.txt
netvizzApplication,35.txt
occurrence,146.txt
review,84.txt
outcomes,157.txt
cells,45.txt
tumor,10.txt
BRCA1/2,110.txt
survival,152.txt
100000Person-years,117.txt
DAU,91.txt
highVariability,95.txt
it,188.txt
detailedRoles,131.txt
cancer,192.txt
bleedingRisk,160.txt
innateImmuneSystems,84.txt
we,68.txt
it,197.txt
highHeterogeneity,200.txt
tumorMarkers,206.txt
impact,169.txt
occurring,44.txt
surgicalExcision,220.txt
952PercecntOfthePostmenopausalWomen,146.txt
remarkableImprovements,9.txt
association,61.txt
number,241.txt
diagnosis,18.txt
psychologicalAspects,231.txt
aim,188.txt
magneticResonanceImaging,97.txt
ddtSprays,24.txt
METHODS,71.txt
informationNeedsVary,23.txt
interleukin6,156.txt
manyPatients,72.txt
stromalExpression,233.txt
lesion,220.txt
coxHazardRegressionAnalysis,117.txt
12331Users,66.txt
it,111.txt
targetVolume,104.txt
woman,73.txt
recentEpigenomeStudies,225.txt
p,4.txt
Downregulation,125.txt
conventionalChemotherapyDrugs,46.txt
patients,19.txt
breastCancer,218.txt
we,170.txt
It,83.txt
risk,142.txt
xenograftMice,82.txt
selectedPatients,151.txt
changes,225.txt
study,16.txt
polymorphisms,95.txt
interaction,219.txt
lisbonRegion,1.txt
hotIssue,170.txt
tumorNippleDistance,109.txt
features,144.txt
similarExperimentalParameters,236.txt
importantNumber,171.txt
metastasis-free,72.txt
recurrentHyperprolactinemia,57.txt
underlyingIncrease,115.txt
membraneTypeMr,132.txt
186S,194.txt
miRNAs,20.txt
ongoingTrials,143.txt
theirInhibition,135.txt
breastCancerCases,174.txt
Acupuncture,151.txt
theranosticNanoplatform,159.txt
causes,79.txt
ourMethod,36.txt
capabilities,105.txt
balfContent,48.txt
we,48.txt
decreasedRisk,243.txt
patient,197.txt
bLymphocyteChemoattractant,48.txt
acromegaly,202.txt
novelTargetedTherapeuticOptions,136.txt
probe,134.txt
results,68.txt
bioimpedanceAnalysis,19.txt
eralphaTranscription,70.txt
excision,220.txt
VEGF-D,16.txt
It,45.txt
c1711,89.txt
growth,221.txt
surfaceMorphology,9.txt
its,95.txt
flankingCgi,58.txt
cTn,142.txt
sosValues,36.txt
tumorSite-specificInformation,23.txt
cancerRiskPerception,138.txt
expression,246.txt
We,190.txt
underlyingCauses,89.txt
perfluorohexane,159.txt
stigmatization,177.txt
olderWomen,129.txt
Findings,240.txt
latencyPeriod,72.txt
selectedOptimalFeatureSubsets,170.txt
understanding,138.txt
We,6.txt
novelPowerfulTechnique,136.txt
Treatment,57.txt
her2-targetedTherapies,201.txt
466Percecnt,202.txt
effects,82.txt
suchSymptoms,151.txt
strategies,92.txt
mortalityRates,44.txt
presence,47.txt
properties,14.txt
clinico-pathologicalRiskFactors,118.txt
subtype,127.txt
mitochondrialFission,77.txt
the,144.txt
kaplan-meierCurves,103.txt
risk,146.txt
Screening,101.txt
findings,192.txt
patients,57.txt
they,174.txt
infertility,25.txt
primaryBreastDiffuseLargeB-cellLymphoma,93.txt
estrogen,21.txt
Circ-EFCAB2,137.txt
highIndex,220.txt
it,32.txt
breastCancer,193.txt
Mammographic,113.txt
purpose,228.txt
objective,104.txt
Diagnosis,216.txt
hormone-dependentPositiveBreastCancer,42.txt
quality,245.txt
value,238.txt
it,74.txt
patient,207.txt
pulmonaryMetastases,12.txt
importantPotential,28.txt
brd4Inhibition,135.txt
mastectomizedWomen,5.txt
PFH-PTX@PLGA,159.txt
patients,143.txt
evidence-basedRecommendations,151.txt
we,206.txt
mriImaging,80.txt
Hypoxia,156.txt
proposedMethod,83.txt
complexSurgeries,182.txt
signatures,218.txt
women,101.txt
difference,104.txt
Cell,130.txt
ERBB2,241.txt
synchrotronSources,50.txt
treatmentCompletion,217.txt
numerousGene-expression-basedPrognosticSignatures,218.txt
they,57.txt
regressionModels,1.txt
medianInterval,108.txt
involvement,43.txt
risk,179.txt
tnmStaging,86.txt
medianProgression-freeSurvival,4.txt
optimalCut-offValue,238.txt
nudeMice,244.txt
finding,241.txt
systematicReview,219.txt
third,5.txt
patients,20.txt
expressionLevels,18.txt
adults,201.txt
phosphotyrosineRegulatedProteinComplexes,211.txt
performed,163.txt
itsImportantRole,95.txt
multidrugResistance,125.txt
erythema,78.txt
lessBleeding,160.txt
medianOverallSurvival,119.txt
recentDevelopments,225.txt
flowRate,178.txt
Mutations,213.txt
confidentDiagnoses,232.txt
femalePatients,66.txt
nsaidExposure,66.txt
patients,163.txt
omegaFattyAcids,151.txt
27b,209.txt
aim,41.txt
patients,150.txt
RDD,97.txt
death,42.txt
chemotherapy,168.txt
1444Women,133.txt
higherResolution,218.txt
Women,103.txt
patients,93.txt
Zt/g4-MMAE,128.txt
ctcCounts,178.txt
low-molecular-weightHeparin,160.txt
controls,174.txt
breastCancer,221.txt
substantialRacial/ethnicDisparity,54.txt
strongAssociation,202.txt
studies,102.txt
CellLines,128.txt
9h-pyridoPyrrolizin-9-one,181.txt
it,131.txt
triple-negativeBreastCancer,128.txt
zero-inflatedPoissonRegression,24.txt
aberrantMethylationDetection,226.txt
occurringCancers,47.txt
GDM,68.txt
diagnosis,12.txt
expression,156.txt
This,39.txt
miR-34s,3.txt
directRelationship,135.txt
alternativeContrast-enhancedScreeningTools,210.txt
concerns,230.txt
circulatingSolubleRankl,56.txt
capacities,53.txt
breastCancer,14.txt
c.,89.txt
article,33.txt
itsExpressionLevel,185.txt
erysipelatoidCarcinoma,90.txt
antibody-anchoredMagneticBeads,176.txt
secondTumor,80.txt
otherSignificantConcerns,230.txt
cut-offBalfLevel,48.txt
information,1.txt
CESM,34.txt
pooledUptake,200.txt
30Cm,86.txt
cancerStaging,123.txt
chinesePublic,32.txt
keyRole,71.txt
currentFollow-up,188.txt
lowHealthLiteracy,75.txt
It,35.txt
oneCase,216.txt
menopausalHormoneTherapy,21.txt
chemotherapy,147.txt
disease,1.txt
features,114.txt
risk,138.txt
unusualImmuneProfiles,12.txt
aspect,104.txt
directEffects,187.txt
search,212.txt
approach,50.txt
surgeon,31.txt
time,152.txt
article,83.txt
humanChorionicGonadotropin,169.txt
cells,198.txt
action,153.txt
84Patients,61.txt
metastasize,199.txt
rural-basedTertiaryCancerCareCenter,108.txt
noninvasiveImaging,223.txt
Differentiation,31.txt
their,236.txt
cell,74.txt
Studies,84.txt
rates,161.txt
polymeraseChainReaction,130.txt
Demographics,180.txt
medianAge,152.txt
pyrrolizin-9-one,181.txt
it,107.txt
incidence,76.txt
itsFirstDescription,74.txt
Risk,13.txt
menopause,57.txt
volume,162.txt
precision,7.txt
It,42.txt
Residents,145.txt
GTPase,18.txt
It,46.txt
aspects,231.txt
35-64Years,33.txt
2921Posts,35.txt
note,89.txt
prophylacticBilateralSalpingo-oophorectomy,98.txt
Articles,31.txt
lungCancer,119.txt
mmp2Genes,41.txt
breastCancerCare,54.txt
we,236.txt
metastases,43.txt
progranulin,48.txt
respondents,138.txt
Importantly,226.txt
outliers,116.txt
44Percecnt,12.txt
exosomes,206.txt
large-scaleStudies,110.txt
TAAs,44.txt
probableMechanisms,244.txt
it,93.txt
clinicalFeatures,119.txt
cancer,89.txt
women,243.txt
uterineTumors,199.txt
ruralCancerHospital,108.txt
inverseLongitudinalAssociation,2.txt
littleHelp,149.txt
we,166.txt
epidemiologicalFeatures,32.txt
Progranulin,48.txt
importance,243.txt
contrastEnhancement,49.txt
effect,24.txt
2060Women,119.txt
highSensitivity,239.txt
acceleratedPartialBreastIrradiation,217.txt
nippleAreolaComplexInvolvement,109.txt
cancer,159.txt
mutations,241.txt
patients,27.txt
capillaries,176.txt
dualRole,106.txt
SUMMARY,160.txt
effects,229.txt
spc24Knockdown,221.txt
immunohistochemistry,191.txt
distinctiveGeneticModifications,225.txt
internationalGuidelines,80.txt
responseRate,4.txt
otherDietaryRecommendations,151.txt
tailoredConsiderations,161.txt
triple-negativeBreastCancer,194.txt
MethyLight,185.txt
markers,51.txt
breastCancerScreening,79.txt
use,219.txt
blockade,211.txt
short-termStrategy,227.txt
sialicAcidExpression,234.txt
tract'sMetastases,199.txt
PFS,4.txt
study,183.txt
Japan,23.txt
tertiarySexualHealthCenters,151.txt
neoadjuvantChemotherapyGroups,102.txt
medicalStatus,165.txt
cause,240.txt
furtherResearch,75.txt
multiplexAssay,44.txt
limitedHealthSystemCapacities,53.txt
numericalFull-waveSimulation,36.txt
late-phaseClinicalTrials,153.txt
18-fdgFlux,153.txt
baselineSolubleSt-2Level,163.txt
sentinelLymphNodeBiopsy,52.txt
panel,241.txt
aspirinTherapy,219.txt
SD-CNN,101.txt
compactSynchrotronSources,50.txt
binaryLogisticRegressionModels,1.txt
objective,150.txt
wavelengthConsistencyIndex,116.txt
racialDisparity,187.txt
lymphNodeRatio,123.txt
regulationMechanisms,106.txt
inclusion,225.txt
transmembraneCellDeaths,173.txt
408,27.txt
clinicalPicture,224.txt
association,95.txt
forty-twoHigh-gradeSarcomas,72.txt
leafExtracts,173.txt
they,166.txt
baicalin,82.txt
screeningStrategy,79.txt
featureSelectionMethod,170.txt
bilateralMastectomies,67.txt
transitionProbabilities,69.txt
NLR,238.txt
lungCancer,65.txt
Treatment,76.txt
obstruction,164.txt
agreement,210.txt
tolerabilitytheApatinib,196.txt
symptoms,23.txt
diagnosis,95.txt
maleBreastCancer,177.txt
molecularRegulatoryNetworks,189.txt
It,79.txt
4248BreastCancerPatients,145.txt
characteristicExosomalTumorMarkers,206.txt
interpretation,21.txt
survivalDifferences,72.txt
study,20.txt
We,139.txt
changes,64.txt
We,38.txt
patients,191.txt
simulatedInnerBreastTissue,7.txt
understanding,81.txt
aim,129.txt
we,221.txt
cpgIslands,58.txt
CEDM,101.txt
Uncertainties,186.txt
tumorCells,41.txt
breast,220.txt
fibroblasts,233.txt
risk-reducingStrategies,98.txt
Disease,102.txt
therapy,143.txt
ai-associatedTendinopathy,216.txt
cancerControlPlanning,157.txt
migration,41.txt
focus,195.txt
coxModels,160.txt
papers,75.txt
mastectomies,67.txt
nondestructiveTests,7.txt
expression,234.txt
metabricTrainingSet,192.txt
anti-ronMonoclonalAntibodyZt/g4-drugMonomethylAuristatinEConjugate,128.txt
mass,10.txt
geneticChanges,225.txt
Granuloma,166.txt
patients,218.txt
we,209.txt
targetedTumorAccumulation,159.txt
interventionalProcedures,232.txt
Inhibition,77.txt
identification,87.txt
needleAspirationCytology,215.txt
We,63.txt
increase,16.txt
biomarkers,239.txt
genitalTract,199.txt
healthCenters,151.txt
microRNAs,18.txt
monteCarloFeatureFeatureMethod,192.txt
study,246.txt
hypomethylationSites,58.txt
adult1-yearCancerSurvivors,179.txt
steps,71.txt
cancerResearch,233.txt
detailedAnalysis,115.txt
Studies,226.txt
restoration,81.txt
ourBreastCancerPatients,147.txt
chorea,67.txt
supplements,151.txt
doses,142.txt
history,119.txt
beta-SDG,244.txt
localizedDescription,11.txt
rs5743810ProAllele,13.txt
we,139.txt
carbonDioxideLaserTechnology,151.txt
it,228.txt
sister,85.txt
We,122.txt
it,147.txt
oncologicRisk,72.txt
knowledge,94.txt
Mammography,144.txt
feasibilityStudies,50.txt
summaryHazardRatios,212.txt
Women,214.txt
MRI,216.txt
inhibition,105.txt
adherence,129.txt
target,154.txt
breastCancer,53.txt
mostCommonOnes,215.txt
traumaticNeuroma,220.txt
patients,155.txt
study,202.txt
conservativeTreatment,220.txt
search,120.txt
study,39.txt
We,27.txt
sensitivity,239.txt
pleuralMetastasis,17.txt
centralImplantedVenousAccessDevices,164.txt
freshLeafEthanolicExtract,173.txt
importantRole,47.txt
importantCornerstone,207.txt
mostStigmatization,177.txt
increasedPer2Expression,172.txt
breastSurvival,187.txt
shorterRadiotherapyRegimens,143.txt
We,160.txt
patients,195.txt
Women,21.txt
diagnosis,19.txt
diagnosis,187.txt
supplementalScreening,148.txt
covariance,59.txt
risk,118.txt
gaslessRobot-assistedNipple-sparingMastectomy,122.txt
we,238.txt
total,23.txt
133Controls,174.txt
subjectiveRisk,138.txt
tumors,199.txt
PM,228.txt
exercise,227.txt
it,149.txt
denosumabInjection,26.txt
geneExpressionData,170.txt
133BreastCancerCases,174.txt
currentAnalysis,204.txt
barcodeMode,132.txt
goal,22.txt
proposedTechniqueResults,49.txt
disease,76.txt
familyHistory,119.txt
cancerFibroblasts,233.txt
study,138.txt
she,139.txt
concentrations,16.txt
We,12.txt
Univariate,238.txt
prophylacticCranialIrradiation,76.txt
breastCancer,42.txt
presence,95.txt
analysis,144.txt
equivalentPerformance,236.txt
breastCancerGenetics,158.txt
CLB-Pt-CLB,205.txt
mass,47.txt
review,3.txt
estrogenReceptor,42.txt
characteristics,232.txt
linkage,53.txt
cell-killingEffect,205.txt
furtherUnderstanding,70.txt
gsAlgorithm,170.txt
cylindricalGeometries,9.txt
study,22.txt
immunocytochemicalStudies,51.txt
purpose,124.txt
promisingSupplements,151.txt
theResulting,144.txt
mitochondrialResponse,153.txt
we,171.txt
catheter-relatedObstruction,164.txt
we,234.txt
alternative,53.txt
outcome,151.txt
appearance,38.txt
oralBeta-sdgAdministration,244.txt
presence,60.txt
simulationStudies,63.txt
Breast,202.txt
cancerSusceptibilityGenes,213.txt
It,192.txt
Researchers,24.txt
follow-up,80.txt
radiotherapy,126.txt
omega3FattyAcids,151.txt
activation,140.txt
pharmacokineticParameters,184.txt
definedSubtype,127.txt
Biopsy,232.txt
estrogenicExposure,243.txt
findings,30.txt
aim,165.txt
australianSynchrotron,224.txt
forwardProblem,36.txt
lipidProfiles,236.txt
severalIntelligentTechniques,113.txt
lymphocytes,154.txt
we,223.txt
characterization,211.txt
surgery,118.txt
responseRate,196.txt
breastCancerTreatment,219.txt
ELISA,16.txt
Studies,200.txt
radiomics,194.txt
hundreds,176.txt
aim,169.txt
neuroma,220.txt
dissection,143.txt
detection,235.txt
threeParadigmaticExamples,51.txt
10-foldCross-validation,20.txt
itsWater-bathSetup,36.txt
longNoncodingRnas,190.txt
treatment,94.txt
multivariableLogisticRegressionAnalysis,164.txt
Drp1,77.txt
patients,38.txt
conclusionsWomen,27.txt
incorporation,60.txt
tissueBiopsy,121.txt
three-yearSurvivalRates,147.txt
assay,44.txt
We,245.txt
women,119.txt
identification,218.txt
value,86.txt
furtherResearch,202.txt
decreases,136.txt
overallSurvival,86.txt
radiomicsScore,194.txt
enforcedExpression,18.txt
summary,157.txt
Images,50.txt
association,97.txt
shift,74.txt
article,135.txt
uterineMass,199.txt
eighthEdition,167.txt
study'sObjectives,187.txt
cornerstone,207.txt
breastCancer,132.txt
ddtExposure,24.txt
studies,110.txt
understanding,41.txt
Report,89.txt
frequentLateRelapses,93.txt
imagingTechnique,210.txt
patients,151.txt
breastCancerMetastasis,152.txt
fine-needleAspirationCytology,52.txt
functionalAssessments,223.txt
it,136.txt
they,72.txt
77,32.txt
novelMethod,178.txt
study,187.txt
Data,179.txt
undergoing,25.txt
breastCancer,192.txt
predictors,165.txt
mitochondrialMorphology,77.txt
Data,32.txt
clinicalBreastExamination,138.txt
increase,135.txt
microRNA,71.txt
20BreastCancerPatients,178.txt
Symptoms,76.txt
digitalBreastTomosynthesis,155.txt
definition,75.txt
RNAs,137.txt
multiresolutionResult,144.txt
fiveMutationCarriers,89.txt
mab1e3,154.txt
nuclearAtypiaScoring,59.txt
receptorTyrosineKinasePdgfrb,211.txt
massProduction,176.txt
prognosis,32.txt
TAG72,206.txt
medianTime,147.txt
furtherDevelopment,134.txt
ESR1,152.txt
vascularAdhesionProtein-1,246.txt
women,27.txt
Information,133.txt
itsExpression,140.txt
measurements,116.txt
medianOs,119.txt
symptoms,151.txt
idiopathicGranulomatousMastitis,31.txt
Pyrrolizinones,181.txt
paradigmaticExamples,51.txt
absence,60.txt
Cabergoline,57.txt
breastCancerPatients,129.txt
increasedRisk,118.txt
collectedSignatures,218.txt
essentialsBleedingRisk,160.txt
NCCN,98.txt
estrogens,21.txt
rate,96.txt
osAdvantage,4.txt
itsExpression,131.txt
women,100.txt
fluorescenceImagingExVivo,134.txt
support,35.txt
medianDiagnosisAge,32.txt
neoadjuvantChemotherapy,102.txt
12SampledWomen,138.txt
growth,215.txt
radiomics,62.txt
Irradiation,76.txt
ctcIsolationTechniques,178.txt
aromataseInhibitors,216.txt
highestSe,16.txt
Prevalence,88.txt
breastUltrasound,148.txt
numerousStudies,226.txt
positiveTreatment,118.txt
identification,142.txt
prognosticStagingSystems,167.txt
survey,126.txt
dnaMethylation,226.txt
results,229.txt
scan,121.txt
protocols,8.txt
matchedHealthyTissues,185.txt
Depletion,70.txt
occasionalComplications,217.txt
change,115.txt
miR-511,131.txt
imaging,162.txt
tumours,152.txt
breastCancerProgression,140.txt
platform,178.txt
mostTumors,57.txt
breastCancer,244.txt
intervention,22.txt
difference,183.txt
carbohydrateRestriction,151.txt
betterUnderstanding,81.txt
mutationEvents,241.txt
cellDeath,173.txt
proteinKinaseC/extracellularSignal-regulatedKinasePathway,46.txt
biologicalSubtypes,102.txt
we,142.txt
we,50.txt
chemotherapyRegimens,169.txt
coreNeedleBiopsy,232.txt
advances,167.txt
SUM159PT,106.txt
parameters,184.txt
variousNon-pharmacologicalAdjuvantTherapies,237.txt
imaging,223.txt
it,101.txt
specificEralpha-targetedProbe,223.txt
Data,23.txt
patient,62.txt
manyComputerVisionApplications,114.txt
ourLiteratureReview,220.txt
risk,24.txt
featureSubsets,170.txt
furtherStudies,19.txt
We,201.txt
cohort,200.txt
EosinophilicGranuloma,166.txt
metabolicChanges,240.txt
ratio,123.txt
itsRelevantLimitations,148.txt
pi3k/aktSignaling,131.txt
Period2,172.txt
probableAnticancerMechanisms,244.txt
group1,180.txt
immediateUnmetNeed,14.txt
we,100.txt
education,186.txt
trastuzumab,27.txt
cancer,108.txt
mitochondrialTransmembranePotential,173.txt
focalAsymmetricDensity,31.txt
sexualityEvidence,57.txt
increasingNumber,241.txt
,106.txt
three-lncrnaSignature,190.txt
aim,185.txt
oneHundredElevenPatients,217.txt
association,13.txt
followingStudy,162.txt
suggesting,232.txt
obstetricians,193.txt
aspirationCytology,52.txt
salpingo-oophorectomy,98.txt
mainChallenge,241.txt
Using,188.txt
data,117.txt
guidelines,80.txt
ptyrProteins,211.txt
resultsAberrantExpression,71.txt
Steps,39.txt
extendedAdjuvantTreatment,78.txt
women,146.txt
Patients,120.txt
results,18.txt
abnormalDnaMethylation,226.txt
roboticSurgicalSystems,122.txt
breastCancerRelapse,17.txt
adPatients,66.txt
77Patients,32.txt
heterogeneity,160.txt
expression,61.txt
postOperativeAssessment,147.txt
breastCancer,154.txt
tomography,67.txt
seromaProduction,203.txt
late-stage,145.txt
cancer,120.txt
modificationPathways,84.txt
two-yearStudy,22.txt
breastCancerScreening,33.txt
We,23.txt
proportion,27.txt
age,152.txt
studies,169.txt
quality,187.txt
differentLong-termSurvival,102.txt
2Patients,191.txt
risk,208.txt
accuracy,167.txt
essentialRole,225.txt
time,147.txt
realDataAnalysis,63.txt
non-hodgkinLymphoma,161.txt
differentTreatmentModalities,199.txt
prevention,21.txt
vitaminDActivity,95.txt
furtherAdvancements,68.txt
It,194.txt
it,231.txt
cytogeneticAnalysis,191.txt
rs5743810,13.txt
essentialsRisk,160.txt
number,26.txt
age-matchedSystematicRandom-samplingMethod,117.txt
biopsy,124.txt
limitedLiterature,242.txt
research,75.txt
PB-DLL,93.txt
continuousPattern,93.txt
appropriateSequencing,143.txt
terms,57.txt
retrospectiveReview,217.txt
HADS,111.txt
cancer,218.txt
usedDrugs,216.txt
lymphoma,93.txt
breastCancer,26.txt
Information,12.txt
mechanisms,21.txt
tediousCountingCell,74.txt
tumorFluid,206.txt
familialCancerClustering,202.txt
diagnosticEvaluation,220.txt
breastCancer,31.txt
backgroundTrastuzumab,27.txt
95PercecntConfidenceIntervals,212.txt
largeBreastCancerTissueMicroarray,245.txt
microRNA-22,18.txt
pax6Inhibition,41.txt
contribution,7.txt
breastCancerDetectionMethod,91.txt
plasticity,186.txt
syndromes,67.txt
method,37.txt
almatyCity,145.txt
programs,53.txt
we,160.txt
higherRisk,160.txt
we,241.txt
wordCloud,35.txt
understanding,70.txt
We,78.txt
we,63.txt
Areas,92.txt
P,184.txt
claimsDatabase,160.txt
h&eStaining,162.txt
lungCancer,144.txt
limited-angleFourier-domainSosReconstruction,36.txt
responsibleMechanisms,21.txt
Cancer,171.txt
considerations,161.txt
It,22.txt
methodsDesign,177.txt
binding,156.txt
model,183.txt
of121Patients,147.txt
methylationStatus,58.txt
diagnosis,31.txt
differentStudies,142.txt
we,137.txt
breastCancer,28.txt
Scoring,59.txt
axillarySurgery,143.txt
breastCancer,11.txt
Utilization,21.txt
totalOf121Patients,147.txt
p,119.txt
case,85.txt
westernBlotting,130.txt
femaleNudeMice,162.txt
homologousRecombinationPathway,135.txt
Cells,82.txt
We,216.txt
antibodyPanel,67.txt
comparisonCohort,117.txt
available,99.txt
we,7.txt
simpleLow-costAlternative,53.txt
study,109.txt
mammography,34.txt
percecnt,12.txt
tumors,108.txt
expressionLevels,130.txt
peripheralBloodSamples,169.txt
back-splicingMechanism,137.txt
highSensitivity,176.txt
rituximab,93.txt
we,119.txt
comprehensiveSearch,212.txt
cytology,52.txt
newerDrugDeliveryStrategies,168.txt
expression,131.txt
smallProportion,109.txt
patients,238.txt
caseRecords,108.txt
poly,159.txt
coverageRates,79.txt
maintainedBreastCancerDatabase,102.txt
9398,118.txt
alveolar-interstitialLesions,104.txt
binding,134.txt
We,179.txt
article,207.txt
undergoing,151.txt
sectionLeads,92.txt
Risk,88.txt
expressedCircularRnas,137.txt
clinicopathologicalSignificance,172.txt
RT,126.txt
paraneoplasticAntibodyPanel,67.txt
MRI,207.txt
diagnosis,55.txt
lobularCarcinoma,67.txt
association,2.txt
women,210.txt
first-lineTreatment,4.txt
carcinoma,37.txt
malePatients,103.txt
monteCarloFeatureSelection-basedFeatureSelection-basedComputationalMethod,192.txt
research,202.txt
histoneModifications,127.txt
recommendations,193.txt
patients,47.txt
Patients,100.txt
risk,95.txt
principles,75.txt
most,33.txt
entities,149.txt
primaryBreastCarcinoma,232.txt
study,244.txt
threeDifferentClusters,120.txt
Anthracyclines,142.txt
chemotherapy-inducedNeuropathy,46.txt
sensitiveCells,198.txt
regressionAnalyses,2.txt
women,133.txt
rnaSequenceAnalysis,70.txt
treatment,157.txt
inclusion,89.txt
firstTime,44.txt
growth,244.txt
patients,32.txt
impact,186.txt
successfulQuantification,176.txt
CNN,101.txt
mutationCarriers,89.txt
Trends,115.txt
theirEmergingRole,207.txt
itsDeregulation,172.txt
itsRole,61.txt
concurrentNeuroprotectiveDrugTherapy,76.txt
Diseases,40.txt
skinMetastases,215.txt
its,76.txt
subsequentAxillaryLymphNodeDissection,124.txt
synthesisMethods,9.txt
DOACs,160.txt
elevenPatients,217.txt
earlyBreastCancerDetectionSystems,114.txt
Diseases,167.txt
we,128.txt
intrinsicDisruption,65.txt
contrastAgents,210.txt
19,72.txt
resistance,125.txt
costs,69.txt
knowledgeSummaries,157.txt
necessity,220.txt
numberVariants,192.txt
easternAsianMusculoskeletalOncologyGroup,72.txt
experiences,138.txt
ORR,196.txt
incidenceRates,213.txt
89Participants,2.txt
mass/es,31.txt
VAP-1,246.txt
we,98.txt
therapy,22.txt
symptomaticHeartFailure,27.txt
ourFindings,81.txt
methods,175.txt
breastCancer,20.txt
Cryopreservation,8.txt
breastScreening,33.txt
OR,129.txt
underlying,172.txt
nationwideSurvey,126.txt
we,90.txt
bestAvailableEvidence,193.txt
markers,48.txt
we,56.txt
hereditaryBreast,98.txt
Genetic,156.txt
biopsy,34.txt
presence,240.txt
findings,243.txt
hybridCultures,154.txt
little,245.txt
recommendations,151.txt
we,120.txt
unenhancedMriTechniques,207.txt
humanEpidermalGrowthFactorReceptor2ReceptorStatus,108.txt
found,234.txt
youngMalePatients,103.txt
shapes,9.txt
potentialReduction,219.txt
theirApplication,9.txt
workAbility,2.txt
we,218.txt
routineUse,217.txt
they,94.txt
hypomethylation,58.txt
ernGenturis,94.txt
breastCancer,33.txt
longScanTime,207.txt
previousTherapy,191.txt
DOACS,160.txt
theirAbility,218.txt
trends,115.txt
overallSurvival,246.txt
physician,168.txt
potential,173.txt
DCR,196.txt
purpose,30.txt
observationalStudies,133.txt
results,81.txt
paTreatment,231.txt
We,69.txt
Biomarkers,37.txt
neuropathies,46.txt
causes,89.txt
expression,128.txt
expression,137.txt
kaposiSarcoma,161.txt
yoga,151.txt
Review,92.txt
aim,82.txt
Review,89.txt
breastCancer,39.txt
breastCancer,59.txt
controlTrial,22.txt
studies,226.txt
selectiveBinding,134.txt
miceConditions,162.txt
therapies,127.txt
treatment,216.txt
tangshanPeople,196.txt
therapy,4.txt
Access,5.txt
cancer,128.txt
conjugatedEquineEstrogen,21.txt
RANKL,56.txt
BRCC3,130.txt
priorMedicalHistory,163.txt
volumetricMeasurementSystem,15.txt
it,192.txt
predictors,190.txt
tumorInterstitialFluidDerivedExosomes,206.txt
80,191.txt
anthracyclineChemotherapyAgents,227.txt
comparisons10-yearSurvival,187.txt
mainObjective,108.txt
breastCancer,158.txt
complications,217.txt
their5h-pyridoPyrrolizin-5-oneAnalogs,181.txt
microfluidicChips,176.txt
tumourigenesis,172.txt
miRNA,68.txt
1000Patients,39.txt
understanding,3.txt
smallPopulation,195.txt
higherProportion,19.txt
tomography,36.txt
each,183.txt
Belgium,79.txt
optimalCutoffValues,19.txt
subset,131.txt
signature,218.txt
commonCancerTypes,175.txt
ovarianMetastases,43.txt
per2Expression,172.txt
luminalB-likePatients,102.txt
repair,141.txt
breastCancerPatients,114.txt
higher,202.txt
CTCs,169.txt
significantIncrease,26.txt
mutations,225.txt
maintenance,156.txt
autoantibodies,44.txt
mirnaExpressionProfiles,20.txt
effects,151.txt
excellentPerformance,83.txt
relatedTranscriptionFactorSox9,189.txt
fewStudies,200.txt
clinicalRecords,147.txt
mammography,50.txt
cancer,119.txt
survivalRates,147.txt
Identification,234.txt
vap-1NegativeStaining,246.txt
We,180.txt
Transcripts,138.txt
SPC24,221.txt
level,177.txt
caseReport,65.txt
Data,47.txt
cutaneousMetastasis,215.txt
clinicalApplicability,36.txt
studies,19.txt
higherBalfContent,48.txt
breastCancer-specific10-yearSurvival,187.txt
bloodSamples,169.txt
lesion,90.txt
otherData,32.txt
diseases,66.txt
sites,41.txt
severalIndividuals,85.txt
association,202.txt
patient,215.txt
breastCancer,91.txt
data,32.txt
targetingFxyd3-mediatedPathway,189.txt
chemotherapy,121.txt
relapseRates,17.txt
hsa-miRNA-143-3p,125.txt
healthcareUtilization,64.txt
coxProportionalHazardRegressionModels,133.txt
procedures,232.txt
actualIncidence,21.txt
calvarialLesions,166.txt
upregulation,125.txt
novelty,59.txt
treatmentProtocols,231.txt
Baicalin,82.txt
26894People,160.txt
specificFoodRecommendations,151.txt
materialDetection,175.txt
otherInotherTertiaryCentres,147.txt
nippleInvolvement,109.txt
resultsDiagnosed,108.txt
Patients,72.txt
caDetection,176.txt
newCancerCases,161.txt
firstTime,97.txt
article,148.txt
study,24.txt
similarTowaveletFilter,144.txt
percecnt,108.txt
bl1-subtype,106.txt
development,136.txt
data,47.txt
Surgeons,92.txt
neutrophil-to-lymphocyteRatio,238.txt
clinicalOutcomesDiffer,182.txt
growthPotential,57.txt
inGrowth,221.txt
block,198.txt
tumorAccumulation,159.txt
inflammatoryTumour,107.txt
use,51.txt
manyFeatures,144.txt
researchDevelopment,94.txt
Findings,151.txt
female,10.txt
metastaticDisease,121.txt
diagnosisSystem,49.txt
dynamicSh2ProteinComplexes,211.txt
breastCancerPatients,145.txt
frequentCancer,159.txt
we,133.txt
imagingFeatures,31.txt
Non-linearity,59.txt
balfLevel,48.txt
cutoff,19.txt
studies,219.txt
baselineSt-2Level,163.txt
chineseExpertGroup,100.txt
oncogenicFunctionality,221.txt
dysregulation,131.txt
performance,236.txt
targetedTherapies,127.txt
aim,233.txt
historyPhysicalExamFindings,67.txt
profiles,12.txt
mortality,42.txt
patient,6.txt
archivedFormalin-fixedParaffin-embeddedTissue,245.txt
aberrantDnaMethylation,58.txt
riskFactors,118.txt
msotImaging,134.txt
brcc3Interference,130.txt
women,117.txt
survival,191.txt
significantDifference,104.txt
reverseTranscription-quantitativePolymeraseChainReaction,185.txt
changes,129.txt
asymptomaticWomen,33.txt
biomarker,142.txt
breastCancer,228.txt
adjuvantEndocrineHormonalTherapy,22.txt
blackWomen,187.txt
exosomesCk19,206.txt
it,134.txt
HR,32.txt
virtualReality,228.txt
textureAnalysis,11.txt
time,118.txt
mrSystems,62.txt
pseudotumoralAspect,104.txt
20,27.txt
conditions,229.txt
mammograms,91.txt
screeningPrograms,79.txt
increasedRisk,95.txt
ourResults,221.txt
breastCancer,194.txt
Computer,59.txt
medianFollow-upPeriod,72.txt
cancer,41.txt
patients,1.txt
epigeneticDysregulation,226.txt
we,83.txt
lowCtnLevels,142.txt
studies,75.txt
severePneumopathy,104.txt
differentiation,150.txt
triple-negativeBreastCancer,28.txt
We,209.txt
parameterUncertainty,33.txt
localRecurrence,147.txt
miR-10a,244.txt
hospitalCohort,187.txt
trend,147.txt
majorAdvance,198.txt
expression,120.txt
significantAdvances,142.txt
cancerAssociatedFibroblasts,233.txt
oestrogenReceptorAlpha,70.txt
ourTheoreticalAnalysis,7.txt
Applications,40.txt
12331Non-nsaidUsers,66.txt
hazardRates,66.txt
initialResults,207.txt
mpMRI,60.txt
Rituximab,93.txt
patient,121.txt
state-of-the-artAlgorithms,59.txt
ivimParameters,150.txt
studies,233.txt
Data,119.txt
intelligentTechniques,113.txt
5Percecnt,161.txt
studies,200.txt
dose-dependentReduction,135.txt
leaves,173.txt
classifiers,236.txt
proposedCovariance,59.txt
breastCancer,219.txt
lymphoma,161.txt
stressProbe,173.txt
contraceptiveUse,96.txt
incidence,65.txt
nsaidUsers,66.txt
control,217.txt
commonComplaint,32.txt
itsUsefulness,60.txt
heartFailure,27.txt
systematicCharacterization,211.txt
PALB2,110.txt
survival,119.txt
decreasedExpression,131.txt
humanPapillomavirusScreening,53.txt
endocrineResistance,70.txt
It,95.txt
autoimmuneDiseases,66.txt
greatestDivergences,115.txt
481Women,187.txt
we,14.txt
recurrentWords,35.txt
potentNon-secosteroidalVdrModulator,209.txt
We,218.txt
Metastases,166.txt
Myeloma,166.txt
abbreviatedMriProtocols,148.txt
specificityImprovement,34.txt
we,159.txt
solidTumor,191.txt
radicalSurgicalApproaches,203.txt
literature,242.txt
miRNAs,120.txt
Cells,84.txt
oncoproteins/cancerSuppressors,84.txt
MultipleMyeloma,166.txt
foxc1Function,105.txt
overallMediumSecondTumor-freeTime,118.txt
mir-10aExpression,244.txt
transferLearning,114.txt
review,76.txt
pfh-ptx@plgaSpio-her,159.txt
expression,18.txt
CTCs,178.txt
mutationRatio,197.txt
deregulatedMirnas,131.txt
we,191.txt
largeVariability,200.txt
risks,98.txt
we,201.txt
surgery,143.txt
patients,100.txt
tumors,195.txt
We,153.txt
intensive,80.txt
measurementSystem,15.txt
performance,49.txt
We,67.txt
figures,19.txt
Overexpression,29.txt
China,33.txt
publicHealthCareSystem,187.txt
image,101.txt
recurrenceRates,217.txt
cancer,168.txt
development,134.txt
need,23.txt
percecntConfidenceIntervals,212.txt
troponins,142.txt
ca15-3Detection,176.txt
higher-qualityImaging,167.txt
analysis,191.txt
hereditaryDiffuseGastricCancer,89.txt
nsaidsExposure,66.txt
period,86.txt
patients,164.txt
overview,11.txt
need,120.txt
People,202.txt
furtherStudies,169.txt
breastImagingModality,210.txt
She,139.txt
women,180.txt
probeNir-sn-ggt,29.txt
issues,230.txt
genitalTract'sMetastases,199.txt
sentinelLymphNodeBiopsy,124.txt
aim,224.txt
guidedImagery,151.txt
Literature,75.txt
vap-1Expression,246.txt
breastCancer,202.txt
scarceReports,72.txt
characteristics,1.txt
results,175.txt
foodRecommendations,151.txt
survivalRate,100.txt
tumors,21.txt
brcc3Expression,130.txt
aberrances,197.txt
mir-511Overexpression,131.txt
We,72.txt
patients,61.txt
combinedPanel,44.txt
breastCancer,145.txt
we,106.txt
l-3,106.txt
charts,217.txt
factor-1Scores,184.txt
606Percecnt,108.txt
DDTs,174.txt
disease,197.txt
postmenopausalPatient,197.txt
geometries,9.txt
breastCancer,136.txt
textureFeatures,184.txt
fission,77.txt
we,115.txt
Patients,102.txt
FOXC1,105.txt
thepresence,47.txt
experts,231.txt
l-3Knockdown,106.txt
pneumopathy,104.txt
Resurgery,83.txt
water,176.txt
bloodVesselsFormation,162.txt
breastCancer,141.txt
mechanism,105.txt
histologicExamination,232.txt
histopathologicDistinction,149.txt
improvedDetection,134.txt
overallSurvival,22.txt
fisherDiscriminantAnalysis,184.txt
paclitaxel,46.txt
typicalWoman,177.txt
theirLong-termSurvival,118.txt
betterUnderstanding,3.txt
primaryTumours,152.txt
Therapies,127.txt
study,237.txt
increase,232.txt
role,243.txt
theirSelection,92.txt
use,22.txt
finalMultipleRegressionModel,1.txt
invasion,172.txt
toxicity,217.txt
boneDensity,151.txt
identification,131.txt
S10,104.txt
signalIntensity,134.txt
breastCancer,240.txt
it,42.txt
betterPredictionPerformance,170.txt
trajectoryMembership,183.txt
axillaryDissection,143.txt
25-year-oldWoman,73.txt
omission,143.txt
fineNeedleAspirationCytology,215.txt
we,58.txt
results,108.txt
we,230.txt
lungCancers,226.txt
it,55.txt
volumes,40.txt
We,85.txt
combination,62.txt
detection,134.txt
they,137.txt
microfluidicPlatform,178.txt
microRNAs,81.txt
fewStudies,103.txt
patients,153.txt
prostateCancers,161.txt
woman,177.txt
aberrations,171.txt
case,67.txt
obtainedFeatures,114.txt
Estrogen,42.txt
acuteComplications,217.txt
It,167.txt
We,50.txt
receiving,25.txt
ssdnaAptamerMf3,55.txt
breastCancer,80.txt
patients,108.txt
presence,189.txt
everolimus-exemestaneCombination,104.txt
approach,232.txt
usefulness,26.txt
traumaticBreastNeuromas,220.txt
supportVectorMachine,170.txt
patients,160.txt
amino-terminalFragment,51.txt
aromataseInhibitor-inducedBoneLoss,26.txt
greatestImportance,95.txt
histopathologicalreports,39.txt
healthcarePolicyMakers,207.txt
breastCancer,101.txt
helaCells,130.txt
we,89.txt
alexnetModels,114.txt
averageRisk,148.txt
cutoffValues,19.txt
survivalDistributions,147.txt
random-samplingMethod,117.txt
breastCancer,237.txt
-916,33.txt
dysplasia,191.txt
lungCellCarcinomas,12.txt
staining,6.txt
longitudinalAssociation,2.txt
oxidationPeakCurrent,235.txt
incidence,115.txt
multiparametricMri,60.txt
association,130.txt
metastaticBreastCancer,43.txt
little,214.txt
Change,115.txt
mortality,231.txt
neuropathy,46.txt
lesions,149.txt
ironOxideNanoparticles,159.txt
specimen,10.txt
measures,118.txt
brainMetastases,76.txt
breastCancer,233.txt
patients,131.txt
breastCarcinoma,232.txt
stagingSystems,167.txt
irregularHyperintenseLesion,97.txt
patients,102.txt
effect,82.txt
role,221.txt
skinMetastasis,215.txt
Tumours,147.txt
correlationCoefficient,116.txt
10Mg/kg,128.txt
it,75.txt
lifestyleFactors,112.txt
regressionModel,1.txt
encapsulatedSuperparamagneticIronOxideNanoparticles,159.txt
ctnLevels,142.txt
sonography,148.txt
ipsilateralBreastRecurrence,217.txt
currentUtilizedHistopathologicBiomarkers,11.txt
adjustedProportion,27.txt
parpInhibitors,168.txt
krukenbergTumors,43.txt
solubleMarkers,51.txt
Sutegorization,86.txt
biomarkers,11.txt
14644Patients,200.txt
shallowCnn,101.txt
networks,189.txt
patient,114.txt
brain,76.txt
method,178.txt
Aims,135.txt
study,15.txt
changes,240.txt
systems,122.txt
women,50.txt
threePapers,75.txt
tamoxifen,46.txt
phosphotyrosineProteinComplexes,211.txt
MetastaticLesions,166.txt
youngestCohort,200.txt
testing,83.txt
interplay,9.txt
pfBiomarkers,51.txt
BRCAs,213.txt
We,197.txt
breastCancerControl,157.txt
comparison,161.txt
changes,226.txt
22Deaths,147.txt
improvedCancerTreatment,9.txt
it,82.txt
428BreastCancerPatients,129.txt
brd4Regulation,135.txt
usStandardization,194.txt
cancerCareCenter,108.txt
breastNeuromas,220.txt
bivariateAssociations,183.txt
tumor,26.txt
patients,111.txt
SMARCAD1,87.txt
splenicLymphocytes,154.txt
breastCancer,127.txt
age,39.txt
fibroblastsAdjacent,233.txt
lowerCumulativeHazardRates,66.txt
comprehensiveResearchData,231.txt
relationship,135.txt
antibodyHerceptin,159.txt
mutations,98.txt
patient'sTumorBurden,197.txt
S7,104.txt
greaterthanorequalto10PercecntDecline,27.txt
increase,210.txt